Michael C Wilburn

US Patent:

20030007961, Jan 9, 2003

Filed:

Jun 22, 2001

Appl. No.:

09/886472

Inventors:

Michael Wilburn - Cedar Hill TX, US

International Classification:

A61K038/44
A61K031/726
A61K031/714

US Classification:

424/094400, 514/046000, 514/054000, 514/100000, 514/052000, 514/251000, 514/336000, 514/027000, 514/458000, 435/189000, 536/008000, 536/026130, 536/027300, 536/053000, 544/257000, 546/282700, 549/406000, 549/408000

Abstract:

Orthomolecular Vitamin E derivative compounds, compositions, and their uses for effecting aging and longevity, nerve activity, hematopoiesis and maintenance of blood cells, hepatic activity, nephritic activity, heart and cardiovascular function, pulmonary function, muscular function, cartilage, bone, and joint health, gastrointestinal function, reproductive system function, vision, immune function, cell membrane integrity, and pain and inflammation; preventing or treating diseases or conditions; treating cancers or obesity; and reducing the risk of Sudden Infant Death Syndrome in an animal. The compounds of the present invention are of formula I: or a pharmaceutically acceptable salt, ester, or solvate, thereof, wherein: A, B, C, D, and R are as defined herein.

US Patent:

20030078231, Apr 24, 2003

Filed:

Jun 22, 2001

Appl. No.:

09/886612

Inventors:

Michael Wilburn - Cedar Hill TX, US

International Classification:

A61K031/7076
C07H019/16

US Classification:

514/045000, 536/027300

Abstract:

Orthomolecular Sulpho-Adenosylmethionine derivative compounds, compositions, and their uses for effecting a biological activity in an animal, such as neurochemical activity; liver biology activity; heart and artery function; cartilage, bone and joint health; stomach and/or intestinal lining resistance to ulceration; immune function; cell membrane integrity; and pain and inflammation. The compounds of the present invention are further useful for preventing or treating diseases or conditions; treating viral infections, infectious diseases, leukemia, and obesity; and reducing the risk of Sudden Infant Death Syndrome in an animal. The compounds of the present invention are of formula I: A is 0 or N; and X is a reaction product as defined herein.